Acetaminophen and diphenhydramine as premedication for platelet transfusions: a prospective randomized double-blind placebo-controlled trial

Am J Hematol. 2002 Jul;70(3):191-4. doi: 10.1002/ajh.10119.

Abstract

Non-hemolytic transfusion reactions (NHTR) occur in up to 30% of patients receiving platelet transfusions. Premedication with acetaminophen and diphenhydramine is a common strategy to prevent NHTR, but its efficacy has not been studied. In this prospective trial, transfusions in patients receiving pre-storage leukocyte-reduced single-donor apheresis platelets (SDP) were randomized to premedication with either acetaminophen 650 mg PO and diphenhydramine 25 mg IV, or placebo. Fifty-one patients received 98 transfusions. Thirteen patients had 15 NHTR: 15.4% (8/52) in the treatment arm and 15.2% (7/46) in the placebo arm. Premedication prior to transfusion of pre-storage leukocyte reduced SDP does not significantly lower the incidence of NHTR as compared to placebo.

Publication types

  • Clinical Trial
  • Randomized Controlled Trial
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Acetaminophen / therapeutic use*
  • Blood Group Incompatibility / prevention & control*
  • Diphenhydramine / therapeutic use*
  • Double-Blind Method
  • Female
  • Histamine H1 Antagonists / administration & dosage*
  • Humans
  • Male
  • Placebos
  • Platelet Transfusion*
  • Premedication*
  • Prospective Studies

Substances

  • Histamine H1 Antagonists
  • Placebos
  • Acetaminophen
  • Diphenhydramine